Also, ERBB2, c-myc, and RAS were positive in 86% (12/14) of hepatocellular carcinoma (HCC) patients, and c-myc and Ras have a direct correlation with bile duct malignancy and morphogenesis [17]. The gene discussed is ERBB2; the disease is hepatocellular carcinoma.